Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Leishmania LPG ELISA Kit

Leishmania Leishmania LPG ELISA-Kit Colorimetric-Assay zur Quantifizierung von Leishmania Leishmania LPG.
Produktnummer ABIN997045

Kurzübersicht für Leishmania LPG ELISA Kit (ABIN997045)

Target

Alle Leishmania LPG (LPG) Produkte
Leishmania LPG (LPG) (Leishmania Lipophosphoglycan (LPG))

Reaktivität

Leishmania

Nachweismethode

Colorimetric

Methodentyp

Competition ELISA

Applikation

ELISA

Proben

Serum
  • Verwendungszweck

    The Leishmania ELISA Kit is for the screening of serum antibodies, primarily IgG, for visceral Leishmania using the ELISA technique.

    Analytische Methode

    Qualitative

    Spezifität

    97%

    Sensitivität

    84%
  • Probenmenge

    10 μL

    Testdauer

    < 1 h

    Plattentyp

    Pre-coated

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Lagerung

    4 °C

    Haltbarkeit

    12 months
  • Target Alle Leishmania LPG (LPG) Produkte

    Leishmania LPG (LPG) (Leishmania Lipophosphoglycan (LPG))

    Andere Bezeichnung

    Leishmania

    Substanzklasse

    Species

    Hintergrund

    Visceral Leishmaniasis (VL) is a severe disease with high mortality, caused by parasite members of the L. donovani complex. The vector for transmission is the sand fly, whose carriers of infection are typically dogs. It is a disease endemic to many countries and is a serious problem in many developing nations, particularly with the increasing urbanization of populations. High incidence is encountered in parts of Latin America, East Africa, Middle East, India and China. It is endemic to countries bordering the Mediterranean such as Italy, Southern France, Spain, Portugal, and Northern Africa. In Southern Europe, VL has become the leading opportunistic infection in AIDS patients. Diagnosis of acute VL is often attempted by aspiration of bone marrow for direct parasite identification. The procedure is invasive, painful, dangerous and has a low success rate due to the inability to always isolate parasites from the tissue. Alternatively, serodiagnosis is widely utilized since anti-leishmanial antibody titers are typically high during the acute disease phase. ELISA is the preferred laboratory test for serodiagnosis of VL, although indirect immunofluorescent antibody tests (IFAT) and direct agglutination tests (DAT), using whole parasites, are still widely used in conjunction with ELISA or alone.
Sie sind hier:
Chat with us!